Science

Diego Díaz-García: A Promising Shift in Neuro-Oncology Strategies

Diego A. Díaz García/X

Aug 6, 2025, 06:42

Diego Díaz-García: A Promising Shift in Neuro-Oncology Strategies

Diego Díaz-García, Medical Oncologist, CEO, Founder at CánCare – Advanced Specialty in Oncology, shared a post on X about a paper by Thomas Kisby et al., published in Nature Reviews Clinical Oncology.

“Glioblastoma can begin to regrow just days after surgery.

Locoregional nanotechnologies offer a way to target the resection margin during this critical window.

A promising shift in neuro-oncology strategies.”

Title: Targeting the glioblastoma resection margin with locoregional nanotechnologies

Authors: Thomas Kisby, Gerben R. Borst, David J. Coope, Kostas Kostarelos

Read The Full Article at Nature Reviews Clinical Oncology.

Diego Díaz-García: A Promising Shift in Neuro-Oncology Strategies

More posts featuring Diego Díaz García on OncoDaily.

cancer David J. Coope Diego Díaz García Gerben R. Borst glioblastoma Kostas Kostarelos Nature Reviews Clinical Oncology OncoDaily Oncology Thomas Kisby

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...